Tag: COVID-19


  • What the Science Really Says About Ivermectin for COVID-19

    What the Science Really Says About Ivermectin for COVID-19

    Intro: The ivermectin buzz in the early pandemic From the outset of the COVID-19 crisis, ivermectin attracted attention beyond its established role as a parasite medication. Early, small studies and social media chatter led some to claim it could prevent or treat COVID-19. Public interest surged even as major health bodies urged caution. Here’s what…

  • Ivermectin and COVID-19: What the Science Really Says

    Ivermectin and COVID-19: What the Science Really Says

    Understanding the ivermectin conversation during the COVID-19 pandemic As COVID-19 spread across the globe, interest in various treatments grew rapidly. Ivermectin, a long-standing antiparasitic drug, became a focal point of discussion far beyond its approved uses. Proponents cited laboratory studies and early clinical reports, while health authorities urged caution until robust evidence emerged. This tension…

  • Trump Policies vs. New Covid Long-Haul Science: Autism, Dormant Cancer, and Brain Aging

    Trump Policies vs. New Covid Long-Haul Science: Autism, Dormant Cancer, and Brain Aging

    Introduction: Policy, Science, and the evolving landscape of long Covid The Covid-19 era reshaped public health policy in ways that continue to ripple through science and medicine. As researchers uncover new facets of long Covid, autism risk signals, dormant cancer cell activity, and brain aging, questions arise about how past policy decisions align with or…

  • What science actually says about ivermectin as a COVID-19 treatment

    What science actually says about ivermectin as a COVID-19 treatment

    Introduction From the outset of the COVID-19 pandemic, multiple drugs were explored as potential treatments. Ivermectin, a drug long used to treat parasitic infections, drew attention early on as a possible COVID-19 remedy. Across media and social networks, claims that ivermectin could be a cure-all spread quickly. Here’s a clear, evidence-based look at what science…

  • Long Covid Policy Gaps and Health Risk Trends in 2023–24

    Long Covid Policy Gaps and Health Risk Trends in 2023–24

    Introduction: Policy Shifts and Emerging Health Realities The debate over how federal policies intersect with evolving medical knowledge has intensified as scientists uncover new facets of covid’s long-term effects. In the wake of May 2023 statements that the national covid emergency had ended, researchers and clinicians continue to map risks associated with long covid, including…

  • Can You Catch COVID Again While Long COVID? A Doctor Explains

    Can You Catch COVID Again While Long COVID? A Doctor Explains

    Understanding the question: reinfection and long COVID Many patients living with long COVID wonder if they can catch COVID again while still dealing with lingering symptoms from a prior infection. The simple answer is: yes, reinfection is possible. COVID-19 is caused by the SARS-CoV-2 virus, which mutates over time. New variants can partly evade the…

  • Comprehensive Reform Empowers Ethiopia to Weather Shocks, Says Finance Minister

    Comprehensive Reform Empowers Ethiopia to Weather Shocks, Says Finance Minister

    Overview: A Reform-Driven Shield Against Shocks Ethiopia’s long‑term reform program has built resilience against a series of external and domestic shocks, according to Finance Minister Ahmed Shide. In a press briefing tracing seven years of policy work, Shide highlighted how structural changes—from fiscal consolidation to revenue reform and debt management—have helped the country absorb the…

  • Comprehensive Reform Enables Ethiopia to Navigate Shocks, Says Finance Minister

    Comprehensive Reform Enables Ethiopia to Navigate Shocks, Says Finance Minister

    Introduction: A Seven-Year Reform Arc In Addis Ababa on January 22, 2026, Finance Minister Ahmed Shide highlighted a sweeping package of reforms that have fortified Ethiopia against a series of shocks—from the COVID-19 pandemic and climatic droughts to inherited debt burdens. Over the past seven years, the government’s comprehensive reform agenda has focused on strengthening…

  • IMF’s $70B Lifeline for Sub-Saharan Africa during COVID-19

    IMF’s $70B Lifeline for Sub-Saharan Africa during COVID-19

    The International Monetary Fund (IMF) committed substantial financial support to Sub-Saharan Africa as the COVID-19 pandemic disrupted economies, currencies, and public health systems. According to Abebe Aemro Selassie, Director of the IMF’s African Department, the fund mobilized close to $70 billion in financial assistance to help the region weather the crisis. The figure reflects a…

  • IMF Disbursed About $70 Billion to Sub-Saharan Africa During COVID-19 Crisis

    IMF Disbursed About $70 Billion to Sub-Saharan Africa During COVID-19 Crisis

    Overview: IMF’s Pandemic Support to Sub-Saharan Africa The International Monetary Fund (IMF) mobilized substantial financial backing for Sub-Saharan Africa during the most intense period of the COVID-19 crisis. In a disclosure that underscores the urgency of the pandemic response, Abebe Aemro Selassie, the IMF’s Director of the African Department, confirmed that the fund channeled close…